Venessa Tsang
Associate Professor Tsang is Clinician Researcher at the University of Sydney and Senior Staff Specialist in Endocrinology at Royal North Shore Hospital, with a primary clinical and research focus on endocrinology and cancer. Since her PhD on the Molecular Pathogenesis of Phaeochromocytoma and Paraganglioma at the Kolling Institute of Medical Research, she is now an internationally recognised researcher on endocrine immunotherapy related adverse events. She has successfully co-supervised three PhD Students to completion on Thyroid Immune Related Adverse effects, Checkpoint inhibitor associated diabetes, and Phaeochromocytoma, and is currently supervising a student on the Pituitary immune related adverse effects. She has been the invited guest editor for Frontiers in Endocrinology and previous editor for the Internal Medicine Journal and Clinical Thyoidology. Her research has changed clinical practice, particularly with the publication of international guidelines on management of diabetes associated with cancer in 2025. Dr Tsang has also maintained research focus on aggressive thyroid cancer, Graves’ disease and type 3c diabetes. Dr Tsang is also the co-chair of the Northern Sydney Local Health District Diabetes and Endocrine Clinical Advisory Group, co-chair of the Endocrine subcommittee for the Agency for Clinical Innovation (ACI), and co-ordinator of the NSW ACT Endocrine Meetings. She is also the final year co-ordinator for the Sydney Medical Programme, University of Sydney, supervising over 280 students each year during the final Preparation for Practices year.
Abstracts this author is presenting: